PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 66: Articles 32501-33000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Sexual counseling with adult retarded--an integral part of a planned parenthood clinic services.
  2. A short history of the psychology of contraception in France. [Petite histoire de la psychologie de la contraception en France.]
  3. Short-term and long-term results of the massive use of intrauterine contraception. [Blizhaishie i otdalennie rezultaty massovovo primeneniya vnutrimatochnoi kontratseptsii.]
  4. Should social workers be involved in family planning?
  5. Side effects of contraceptives on oral cavity tissues. [Effetti collaterali dei contraccettivi a carico dei tessuti orali.]
  6. Side effects of oral contraceptives.
  7. Side effects of oral contraceptives. [Nebenwirkungen der Ovulationshemmer.]
  8. Side effects of oral contraceptives. (Letter to the editor)
  9. Side effects of oral contraceptives. (Letter to the editor)
  10. Side-effects of oral contraceptives. (Letter)
  11. Side-effects of oral-contraceptives. (Letter to the editor)
  12. The significance of oral contraceptives in causing chromosome anomalies in spontaneous abortions.
  13. Simultaneous administration of oral contraceptives and thyroid hormones? [Gleichzeitige Gabe von oralen Kontrazeptiva und Schilddrusenhormones?]
  14. Singapore. (Family Planning Programs)
  15. Skin prophyria after administration of oral contraceptives. [Porphyries cutanees apres prise de contraceptifs oraux.]
  16. A small failure in birth control.
  17. Ethical issues in family planning for hospitalized psychiatric patients.
  18. Ethics of research in contraceptive development: the experience of the Ford Foundation.
  19. Evaluating family planning program effectiveness and efficiency.
  20. Evaluation of a training program in family planning: the case of Iran.
  21. Evaluation of d-norgestrel 1.0 mg as a post-coital contraceptive.
  22. Evaluation of D-norgestrel as post-coital contraceptive and its effect on the endometrium and lipid levels (Abstract) [Evaluacion del D-norgestrel como contraceptivo post-coital y su influencia sobre el endometrio y el lipidograma.]
  23. Evaluation of family planning in health services.
  24. Evaluation of family planning programmes in developing countries.
  25. Evaluation of implementation systems for family planning and population programmes in Malaysia.
  26. Evaluation of maternal and child health and family planning programme in Madura Mills Limited.
  27. Evaluation of National Family Planning Program in Korea.
  28. An evaluation of the Danfa Comprehensive Rural Health and Family Planning Project in Ghana.
  29. An evaluation of the economic cost and effectiveness of the Barbados Family Planning Association. (Doctoral dissertation, New York University, 1973.)
  30. An evaluation of the Family Planning Management Information System Project MSH - AID/csd 3298.
  31. An evaluation of the Population/Family Planning Project in Tunisia.
  32. Evaluation of the Profamilia rural family planning program.
  33. Evaluation system of the family planning program in Nepal.
  34. Evolution and limits of contraception. [Evolution et limites de la contraception.]
  35. Examinations with a monohormonal oral contraceptive agent (Continuin)
  36. An exercise for design of action systems for family planning programme at field level: a framework of family planning clinic management.
  37. The expanding role and scope of practice of all categories of midwives and traditional birth attendants in the field of family planning.
  38. Experience with intrauterine contraception by adolescent women.
  39. Experiences of a long-term study of oral contraceptive use in the young industrial town of Schwedt/Oder. [Erfahrungen einer Langzeituberwachung bei oraler Ovulationshemmer-Einnahme in der jungen Industriestadt Schwedt/Oder.]
  40. An experimental design for family planning program evaluation.
  41. The extent of contraceptive practice.
  42. The extent to which midwives and traditional birth attendants are involved in maternal and child health/family planning services of Thailand.
  43. A factor analysis model to study variation of family planning performance in India.
  44. Factors affecting the choice of contraceptive method by a group of OEO patients.
  45. Factors influencing the acceptability and prolonged use of oral contraception.
  46. Facts and figures on population and family planning programs.
  47. Failures and resistance to contraception. [Les echecs et la resistance a la contraception.]
  48. Family aspects of nonuse of contraceptives in adolescence.
  49. Family Life and sexuality--Planned Parenthood of Snohomish County and City of Everett, revenue-sharing grand project.
  50. Family planning administrators and commercial marketing executives.
  51. Family planning among Aborigines.
  52. Family planning and agricultural development: experiences of an operating programme.
  53. Family planning and contraception. 1. Family planning, abortion. [Familienplanung und Kontrazeption. Folge 1: Familienplanung, Schwangerschaftsunterbrechung.]
  54. Family planning and contraception. 2. Sex education and contraception -- ovulation inhibitors, minipills, IUDs, sterilization. [Familienplanung und Kontrazeption. Folge 2: Aufklarung und Kontrazeption -- Ovulationshemmer, Minipille, IUDs, Sterilisation.]
  55. Family planning and contraception. [Familienplanung und Empfaengnisverhuetung.]
  56. Family planning and economic development in an integrated population. Policy in India.
  57. Family planning and infant mortality rate decline in the United States.
  58. Family planning and its integration with MCH.
  59. Family planning and malaria control: some parallels between two large-scale health-related programs.
  60. Family planning and maternal and child health services.
  61. Family planning and mobile under-fives clinics.
  62. Family planning and population policy.
  63. Family planning and population policy: theses presented to the Symposium on Possible Elements of Society's Population Policy in the SFRY, Belgrade, September 1973.
  64. Family planning and population programs in developing countries: organization and management. (Annotated bibliography Vol. 2, No. 2))
  65. Family planning and sex education via nationwide radio in Costa Rica: an analysis of listeners' response.
  66. Family planning and televised messages (1964-1975) [Le planning familial et les messages televises (1964-1975)]
  67. Family planning as a method of prevention.
  68. Family planning by periodic abstinence.
  69. Family planning clinics play a major role in VD screening.
  70. Family planning counseling.
  71. Family planning democratized.
  72. Family planning education of the male in Taiwan area, Republic of China.
  73. Family planning educational materials: selection, development and use.
  74. Family planning evaluation using census, vital and program statistics.
  75. Family planning fact book of New York City. The profiles include various data available for selected years, 1960-1973.
  76. Family planning fees for anaesthetists. (Letter to the editor)
  77. Family planning for aidpost orderlies and nurse-aides with Teacher's Guide.
  78. Family planning for better maternal and child health.
  79. Family planning for fees anaesthetists. (Letter to the editor)
  80. Family planning for Iranian auxiliaries.
  81. Family planning for the mentally handicapped.
  82. Family planning in a part-Aboriginal community 1970-to 1973.
  83. Family planning in Africa.
  84. Family planning in Bali.
  85. Family planning in Brazil.
  86. Family planning in Cuba 1974.
  87. Family planning in five continents.
  88. Family planning in Gujarat (1974-75); an innovative approach.
  89. Family planning in Hungary. [Familienplannung in Ungarn.]
  90. Family Planning in industry.
  91. Family planning in Mali.
  92. Family planning in Nicaragua: a description of program management.
  93. Family planning in rural areas of eastern Uttar Pradesh.
  94. Family planning in South Carolina: a process of growth and development.
  95. Family planning in the context of social and economic change.
  96. Family planning in Tunisia. [La planification familiale en Tunisie.]
  97. A family planning information system for Costa Rica.
  98. The family planning issue.
  99. Family planning must for better living.
  100. Family planning nurse practitioners in the United States.
  101. Family planning performance in India.
  102. Family planning performance in India: some causes for variations.
  103. Family planning perspective for Haryana State.
  104. Family planning program management and evaluation: a crucial - and changing - relationship.
  105. The family planning program of the Philippines.
  106. Family planning programme in India: some achievements and problems.
  107. Family planning programme in Indian Telephone Industries (I.T.I.), Bangalore.
  108. The family planning programme in Rajasthan.
  109. Family planning programme need for self-examination.
  110. The family planning programme of the Manila Electric Co.: a case study.
  111. Family planning programmes and services in the private and public sector undertakings in India.
  112. Family planning programs and fertility declines in developing countries.
  113. Family planning services and the distribution of black Americans.
  114. Family planning services in industry: a survey.
  115. Family planning services in the People's Republic of China.
  116. Family planning services in the United States.
  117. Family planning services: consumers' evaluations.
  118. Family planning services: Maryland: focus for state initiative.
  119. Family planning statistics 1965 to 1973.
  120. Family planning statistics 1965 to 1973: Africa, Asia, Latin America.
  121. Family Planning still a right. (Conference report 2)
  122. (Family planning survey for males questionnaire and instructions.)
  123. Family planning via the airwaves: radio campaign in Colombia.
  124. Family planning workers and mass vasectomy camps.
  125. Family planning, maternal and child health, and nutrition with special reference to mothers and children: guidelines for DEIDS planning--I. August 1973.
  126. Family planning, part of maternal health care, spurring record low infant, mother death rates in Cuba.
  127. Family planning.
  128. Family planning.
  129. Family planning/population programmes and policies.
  130. Family planning: a resume.
  131. Family planning: AID rage, patient outrage.
  132. Family planning: pitting the private sector against a public problem.
  133. Family planning: the role of the Chambers of Commerce and Employers' Organisation.
  134. Family-planning services. (Letter)
  135. Fees for contraceptive services. (Letter to the editor)
  136. Fees for family planning services. (Letter to the editor)
  137. Female contraception by immunization with HCG - prospects and status.
  138. Female sterilization as a part of the family planning armament in Indonesia.
  139. Fertility after hormonal contraception. (Abstract only)
  140. Fertility and family planning among white teenagers in metropolitan Atlanta.
  141. Fertility and family planning in Thailand: results from two rounds of a national study.
  142. Fertility and family planning in Thailand: results of the second round of a national survey.
  143. Fertility and family planning in Thlabane.
  144. Fertility control through steroid hormones used as contraceptives in the woman. [Control de la fertilidad de la mujer por medio de esteroids hormonales usados como contraceptives.]
  145. Fertility decline and participation in Georgia's family planning program: temporal and areal associations.
  146. Fertility potential of the couples as a basis for setting priority for family planning services: an operational scheme.
  147. Fertility rates decline sharply after countries adopt family planning programs.
  148. Fertility reduction in an MCH/family planning program: a model for projection.
  149. Fiji (Family planning)
  150. First results of radioimmunological determination of LH and FSH during hormonal contraception.) (Abstract only. [Erste Ergebnisse der radioimmunologischen LH- und FSH-Bestimmung unter h ormonaler Kontrazeption.]
  151. A five-year plan for family planning services and population research: fourth progress report to the Congress of the United States, pursuant to section 5, public law 91-572.
  152. Focal nodular hyperplasia of the liver and intrahepatic hemorrhage in young women on oral contraceptives.
  153. Focal nodular hyperplasia of the liver, benign hepatomas, oral contraceptives, and other drugs affecting the liver.
  154. For involvement of the working class in family planning in India.
  155. Francophone countries. (Family planning programs)
  156. Gall-stones and oral contraceptives.
  157. The Gambia (Family planning)
  158. Gastroenteritis causing failure of oral contraception.
  159. Genetic screening and genetic counseling: knowledge, attitudes, and practices in two groups of family planning professionals.
  160. The Georgia Family Planning Pilot Program for Payment for Sterilization.
  161. Ghana. Family planning programs.
  162. Gonadotrophin hormone releasing tests in women receiving hormonal contraception.
  163. Gonorrhea detection in a family planning clinic: a cost-benefit analysis of 2,000 triplicate cultures.
  164. Government policy and personal family planning approval in conflict settings: the case of the Muslim minority in the southern Philippines.
  165. Government-directed family planning (Letter) [Statdirigeret familieplanlaegning.]
  166. Government-directed family planning and its theoretical basis. [Statsdirigeret familieplanlaegning og dens teoretiske grundlag.]
  167. Governmental policy and personal family planning approval in conflict settings: the case of the Muslim minority in the Southern Philippines.
  168. Granny midwives can help with family planning in developing lands; in Iran they insert, remove IUDs.
  169. Gravigard - a new intrauterine contraceptive device. [Gravigard - nowa wewnatrzmaciczna wkladka antykoncepcyjna.]
  170. The growth in use of oral contraceptives in Melbourne 1961-1971.
  171. Guatemala. (Family planning programs)
  172. Guide to "Blue Lady" oral contraceptives.
  173. Guidelines for the evaluation of MCH/family planning programmes. Regional seminars on evaluation of family planning programmes, Manila, October 2-8, 1975.
  174. Gynecological use of a phlebokinetic drug, with particular reference to its association with oral contraceptives. [L'applicazione in ginecologia di um farmaco flebocinetico con particolare riguardo all'associazione di esso con i contraccettivi orali.]
  175. Haemostatic and biochemical effects of oral contraceptives. (Abstract only)
  176. Health and family planning Saturation project for Korea. No 489 11 580 649.
  177. Health benefits of family planning: Information for social workers about reproduction and health.
  178. Health of women and family planning.
  179. Health status of women after prolonged use of hormonal contraceptives. [Zdravstveno stanje zensk po daljsi uporabi hormonskih kontracipiensov.]
  180. The health team in planned parenthood.
  181. Hemoperitoneum from liver cell adenoma in a patient on oral contraceptives.
  182. Hepatic cell adenomas, spontaneous liver rupture, and oral contraceptives.
  183. Hepatic nodular hyperplasia after oral contraception. 2 new cases. [Hyperplasie nodulaire hepatique apres contraception orale. Deux nouveaux cas.]
  184. Histological and histochemical studies of the endometrium in users of copper-T intra-uterine contraceptive device (T Cu 200)
  185. Histological evidence of carcinoma in a hepatic tumour associated with oral contraceptives.
  186. The history of birth control in the United States: a working bibliography.
  187. History of the application of the postpartum principle to family planning.
  188. A holistic approach to study family planning programme in U.P.: framework and findings.
  189. Homocystine, atherosclerosis and thrombosis: implications for oral contraceptive users.
  190. Hong Kong. (Family planning programs)
  191. Hormonal contraception and nutrition.
  192. Hormonal contraception or therapy and altered immunity. (Letter to the editor)
  193. Hormonal contraception, tryptophan metabolism and depression. [Hormonale Kontrazeption, Tryptophanstoffwechsel und Depression.]
  194. Hormonal contraception. Sequential formulations and the endometrium.
  195. Hormonal contraceptives and myocardial infarct. [Hormonelle Antikonzeptiva und Myokardinfarkt.]
  196. Hormonal contraceptives and plasma sex hormone binding globulin.
  197. Hormonal contraceptives and sex hormone-binding globulin capacity. (Abstract only)
  198. Hormone-releasing silicone-rubber intrauterine contraceptive devices: effect of incorporation of various compounds on intrauterine devices in rats.
  199. Hospital based family planning in rural Africa: some lessons from the Midwestern State of Nigeria.
  200. How to set up an effective contraceptives display.
  201. Human rights and welfare aspects of family planning: report presented to the International Planned Parenthood Conference, Brighton, October 1973.
  202. Hyperlipidaemia and pancreatitis associated with oral contraceptive therapy.
  203. Hypertension and oral contraception. [Hypertension og orale kontraceptiva.]
  204. Hypertension developing in women using oral contraceptives. [Kilka uwag na temat nadcisnienia tetniczego u kobiet stosujacych doustne srodki antykoncepcyjne.]
  205. Hypertension reviews: oral contraceptives.
  206. Hysteroscopic removal of occult intrauterine contraceptive device.
  207. The identification, selection and use of oral contraceptives.
  208. Idiopathic pulmonary emboli associated with oral contraceptives, treated by embolectomy by extracorporal circulation. [Embolie pulmonaire idiopathique sous contraceptifs oraux, traitee par embolectomie sous circulation extra-corporelle.]
  209. II. Elective abortion and resistance to contraception. [II. Avortement volontaire et resistances a la contraception.]
  210. ILO Asian Regional Seminar on the Role of Labour Administrations in Population Education and Family Planning in the Organised Sector, Bangkok, Thailand, November 26-December 1, 1975: country papers.
  211. Immunological processes with contraceptive effect from an andrological viewpoint. [Immunologische Prozesse als Konzeptionshindernis aus andrologischer Sicht.]
  212. Impact of family planning programme on births.
  213. The impact of organization of family planning clinics on waiting time.
  214. The impact of subsidized family planning programs on contraceptive use in low income neighborhoods of selected U.S. cities.
  215. The impact on fertility of Singapore's family planning program.
  216. The impact on fertility of Taiwan's family planning program.
  217. Impact on school education of India's family planning programme.
  218. Impacts of family planning field worker's home visits on acceptance of family planning in Korean rural areas (author's transl)
  219. Impediments to family planning. Obstacles to a mentality of foresight. [Les entraves au planning familial. Les obstacles a une mentalite de prevoyance.]
  220. Implications of legal abortion for family planning program evaluation.

     

  221. The importance of sterilization in the Tunisian family planning programme.
  222. Incidence of blastomyces and trichomonad infections during the use of hormonal and intrauterine contraception. [Haufigkeit von Sprosspilz- und Trichomonadeninfektionen bei Anwendung hormonaler und intrauteriner Kontrazeption.]
  223. Incidence of Candida infections and Yeasts in women using contraception. [La prevalence des infections a Candida et aux champignons levuriformes chez les femmes utilisant des moyens contraceptifs.]
  224. Increasing the effectiveness of traditional birth attendants or hilots as family planning motivators through transportation allowances.
  225. Increasing youth programmes in family planning.
  226. Independence of oral contraceptive-induced changes in glucose tolerance and plasma cortisol levels.
  227. India's family planning programme - a critical review.
  228. The Indian family planning programme - an assessment of past performance.
  229. The indigenous midwife in Asia--supporter or opponent of family planning?
  230. Individual dosage of steroid contraceptives. [Zur individuell angepassten Dosierung kontrazeptiver Steroide.]
  231. Indonesia (Family planning)
  232. Indonesia. (Family planning programs)
  233. The Indonesian national family planning program.
  234. Indonesian population policies beyond family planning.
  235. Influence of age, sex, and oral contraceptives on human blood cholinesterase activity.
  236. Influence of copper intrauterine contraceptive devices (CU-7-IUD) on the menstrual blood-loss.
  237. Influence of dietary lipids on iron and copper levels of rats administered oral contraceptives.
  238. Influence of hormonal and intrauterine contraceptives on human sperm migration in vivo and in vitro.
  239. The influence of hormonal contraceptives on sex hormone binding globulin (SHBG) capacity.
  240. Influence of hormonal contraceptives upon carbohydrate metabolism in women with abnormal glucose assimilation during previous pregnancy. [Einfluss hormonaler Kontrazeptiva auf den Kohlenhydratstoffwechsel bei Frauen mit abnormer Glukoseassimilation in vorausgegangener Schwangerschaft.]
  241. The influence of institutional and convenience factors on postpartum family planning acceptance in Medellin, Colombia.
  242. Influence of oral contraceptive agents (OCA) on vitamin B-12 absorption and plasma level. (Abstract only)
  243. The influence of oral contraceptives on serum folate and cervical cytology. (Abstract only)
  244. Influence of the female sexual cycle and of oral contraceptives on the heme and porphyrin synthesis in rat liver. (Abstract)
  245. Information and education in perspective: the Dominican Republic family planning program.
  246. Information meeting about hormonal contraception and the abortion situation. [Informationsmode om hormonal anticonception og abortsituationen.]
  247. Information, education, and communication activities on family planning and mother's club activity in Korea.
  248. Inhibition of LH-RH-stimulated release of LH and FSH by oral contraceptives. [abstract]
  249. Injectable contraceptive, the promising alternative.
  250. Innovative approach to male family planning: a success story.
  251. Innovative systems of delivering family planning services in Latin America and the Caribbean: present and future.
  252. Instant sagot: hotline for advice on family planning.
  253. Institutional and individual views of male involvement in family planning.
  254. Instructions No. 13 of 1974 of the Minister of Health to amend Instructions No. 23 of 1973 of the Minister of Health on the prescribing and supply of hormonal contraceptives.
  255. Insulin and proinsulin secretion under contraceptive steroid administration. [Insulin- und Proinsulin-Sekretion bei Anwendung antikonzeptioneller Ster oide.]
  256. Insulin metabolism, insulin sensitivity and hormonal responses to insulin infusion in patients taking oral contraceptive steroids.
  257. The integrated approach in the provision of family planning services: status, problems and prospects.
  258. Integrated approaches to family planning services delivery.
  259. Integrating family planning into human services.
  260. Integrating family planning into the Catholic health delivery system of Indonesia.
  261. Integration of child health with family planning.
  262. The integration of family planning into the basic health service delivery system: a useful strategy for the future?
  263. Intelligence quotient in offspring of oral and non oral contraceptive users.
  264. Interaction between action programs and social structural variables: a study of family planning and fertility differentials in 4 Colombian cities.
  265. Interaction of contraceptive progestins and related compounds with the oestrogen receptor. Part 2: effect on tritiated oestradiol binding to the rat uterine receptor in vitro.
  266. Interaction of contraceptive progestins and related compounds with the oestrogen receptor: Part 1. Effect on tritiated oestradiol distribution pattern in the ovariectomized rat.
  267. Interaction of contraceptive steroids and essential nutrients. [Interaccion de los esteroides contraceptivos y los nutrientes esenciales.]
  268. Interim report of International Contraceptive Study Program (ICOSP)
  269. Internal medicine considerations on hormonal contraception. [Internistische Uberlegungen zur hormonalen Kontrazeption.]
  270. International Contraceptive Study Project (ICOSP) on raw materials and local production of contraceptives in developing countries. (Report prepared for United Nations Fund of Population Activities) (UNIDO/ITD. 346, July 23, 1975)
  271. International family planning.
  272. The International Postpartum Family Planning Program: 8 years of experience.
  273. International training program of family planning in Korea.
  274. Interpersonal aspects of contraception. [Aspects relationnels de la contraception.]
  275. The interrelationship between family planning and child health (author's transl)
  276. Intra-uterine contraception in general practice.
  277. Intrauterine contraception with the Antigon-F device.
  278. Intrauterine contraceptive devices and carcinogenetic effect (author's transl)
  279. Intrauterine pressure during contraceptive medication.
  280. Intravaginal rings for contraceptive use: an editorial comment.
  281. Introduction (to measuring the effect of family planning programs on fertility.)
  282. Introduction. (Family planning programs: world review 1974)
  283. Introduction. (Midwives as family planning communicators in Asia)
  284. Introduction: spot announcements and the 25 critical obstacles to family planning.
  285. An inventory of family planning sites: Institutional characteristics, United States, 1974.
  286. Investigations of the serum level of pregnancy-associated alpha-2-globulin during contraceptive treatment by means of radial immunodiffusion method.
  287. Iran. (Family planning programs)
  288. Is Islam against family planning?
  289. Is there presently a male pharmacological contraception? [Gibt es zur Zeit eine medikamentose Antikonzeption beim Mann?]
  290. Islam and family planning. [Islam et planification familiale.]
  291. Issues in the demographic evaluation of domestic family planning programs.
  292. The IUD in family planning programs: programmatic issues.
  293. Karan Singh: India's new start in family planning.
  294. Kerala State test of mail order response to family planning booklet for males.
  295. Keynote address: Voluntary sterilization as a major component of family planning.
  296. Kinship, contraception and family planning in the Iranian city of Isfahah.
  297. Knowledge of birth control methods.
  298. Knowledge, attitudes and practice related to contraceptive methods. [Conocimiento, actitudes y practicas relacionadas con los metodos anticonceptivos.]
  299. Knowledge, attitudes, and practice of family planning in Singapore.
  300. Korea (Republic of). (Family planning programs)
  301. Korean values and family planning.
  302. The labour code and family planning programmes and policies.
  303. Lack of clinical contraceptive efficacy of large doses of R 2323 given before implantation or after a missed period.
  304. Laos. (Family planning programs)
  305. Laparoscopic sterilization as a method of birth control.
  306. Large bowel perforation by intrauterine contraceptive devices.
  307. Law affecting contraception, abortion and sterilization in Europe.
  308. Law No. 74-1026 of 4 December 1974 laying down miscellaneous provisions relating to birth control.
  309. Laws and policies in Europe and Latin America spur family planning and population studies.
  310. Legal restrictions on the distribution of contraceptives in the developing nations: some suggestions for determining priorities and estimating impact of change.
  311. Level of copper in the serum, endometrium and menstrual blood in users of copper-T intrauterine contraceptive device (T Cu 200)
  312. Life table rates and person month ratios as summary statistics for contraceptive trials.
  313. Lipid metabolism in women ingesting Stediril-Wyeth preparation as contraceptives. [Metabolizm lipidow u kobiet stosujacych preparat Stediril-Wyeth w celach antykoncepcyjnych.]
  314. Liver cell adenoma and oral contraceptives: double tumor development.
  315. Liver disease with periportal sinusoidal dilatation: a possible complication to contraceptive steroids.
  316. Liver tumors and oral contraceptives.
  317. Liver tumors and oral contraceptives. (Letter to the editor)
  318. Liver tumors in women on contraceptive steroids.
  319. The localization of intra-uterine contraceptive devices with B-scan ultrasonic echo technique.
  320. Location of the missing intra-uterine contraceptive device.
  321. Long-term contraception by steroid releasing implant: 3. Mode of action of megestrol acetate (MA) administered by subcutaneous silastic implants in women.
  322. Long-term contraception by steroid releasing implants: 4. Biological effectiveness of norethindrone acetate (ENTA) implants in rats and rabbits.
  323. Long-term contraception by steroid-releasing implants. A preliminary report on long-term contraception by a single silastic implant containing norethindrone acetate (ENTA) in women.
  324. Long-term contraception using subcutaneous silastic implants. [Contracepcao a longo prazo com implantes subcutaneos de silastico.]
  325. A long-term follow-up study of women using different methods of contraception. (Abstract only)
  326. Long-term use of contraceptives by IUD acceptors in Taichung, Taiwan.
  327. Long-term use of daily administration of low doses of norgestrel as an oral contraceptive.
  328. Longitudinal study of success versus failure in contraceptive planning.
  329. Lynestrenol as a contraceptive preparation: experience with a micro-dosage formulation.
  330. Macrophages on intrauterine contraceptive devices produce prostaglandins.
  331. Main results of recent Hungarian family planning studies. Family planning studies between 1958 and 1974.
  332. Major aspects of family planning in Pakistan.
  333. Malaysia. (Family planning programs)
  334. Male contraception (vasectomy) [Contraception masculine.]
  335. Male contraceptives under trial.
  336. Male motivation/education: a pilot programme designed to disseminate family planning information exclusively to males.
  337. In Mali: family planning in the service of traditional values. [Au Mali: le planning familial au service des valeurs traditionnelles.]
  338. Malignant hypertension associated with use of oral contraceptives.
  339. Malignant hypertension with irreversible renal failure due to oral contraceptives.
  340. Man in front (sic) of contraception. [L'homme face a la contraception.]
  341. Management development strategies for improvement of family planning delivery systems.
  342. Management improvement of national family planning programme in Malaysia: a draft plan of action.
  343. Management of patients taking oral contraceptives. [Programme de surveillance des patientes sous contraceptifs oraux.]
  344. Management science and the administration of family planning programmes.
  345. Manpower planning for the integration of family planning/health services in a primary health care system, Jamaica.
  346. The marginal family in Chile: social change and woman's contraceptive behavior.
  347. Marital decision-making and family planning.
  348. A marketing management plan for family planning in India.
  349. A marketing perspective for planned parenthood.
  350. Marriage, fertility and family planning in the Kecamatan Serpong: some intermediate and socio-economic variables.
  351. Maternal and child health and family planning services: the contemporary global picture.
  352. Mathematical model approach to family planning in response to effort.
  353. The measurement and utility of the opinion leadership concept for family planning programs.
  354. Measurement of the efficiency of contraceptive methods.
  355. Mechanical contraception. [La contraception mechanique.]
  356. Mechanical methods of contraception. [Les methodes mecaniques de contraception.]
  357. Mechanism of action of a new injectable hormonal contraceptive. [Mecanismos de accion de un nuevo anticonceptivo hormonal inyectable.]
  358. Media development/family planning project for Costa Rica, El Salvador, Guatemala: summary of final report.
  359. Media exposure and interpersonal perception in family planning adoption.
  360. Megaloblastic anemia in a vegetarian taking oral contraceptives.
  361. Men's views of family planning.
  362. The menstrual cycle after withdrawal of oral contraceptives with particular reference to return of ovulation.
  363. Menstrual regulation in family planning services.
  364. Menstruation disorders and contraception. [Troubles des regles et contraception.]
  365. Meperidine and combination oral contraceptives. (Letter to the editor)
  366. Meperidine and combination oral contraceptives. (Letter to the editor)
  367. Mesenteric thrombosis associated with oral contraceptives.
  368. Metabolic changes in women using combined estrogen-progestagen contraception. (Abstract only)
  369. The metabolism of synthetic estrogens in non-users and users of oral contraceptives.
  370. Method preference among Philippine family planning acceptors.
  371. Methods of contraception in use in 1970-1971.
  372. Methods of contraception, sterilization and abortion.
  373. Methods of contraception.
  374. Methods of family planning.
  375. Mexico. (Can patients be educated in a clinic about family planning?)
  376. Mexico. (Family planning programs)
  377. The Middle East and North Africa 1974: an overview. (Family planning programs)
  378. Minipills - contraceptive effect. [Minipiller-antikonsepsjonell effekt.]
  379. Modern trends in contraceptive pharmacology.
  380. Monoclonal human immunoglobulins (IGC Lambda) against ethinylestradiol, oral contraception and arterial pulmonary thrombosis. [Immunoglobine humaine monoclonale, IGC lambda, anti-ethinyl-oestradiol, contraceptif oral et thrombose arterielle pulmonaire.]
  381. Monthly injectable contraceptives. [Anticonceptivoc inyectables mensualmente.]
  382. More on oral contraceptives. (Letter to the editor)
  383. Mother, child, and family health benefit from family planning.
  384. Mothers' clubs in the diffusion of family planning ideas in Korean villages: an illustration of network analysis.
  385. Motivating the masses for family planning in the People's Republic of China.
  386. Motivating workers for family planning.
  387. Motivation for family planning.
  388. Motivational aspects of family planning in India.
  389. Multiclinic evaluation of Gravigard (Cu 7) intrauterine contraception.
  390. Multiple hepatic adenomas associated with an oral contraceptive. (Letter to the editor)
  391. Myocardial infarction in young females on the contraceptive pill. (Letter to the editor)
  392. Myocardial infarction in young women with special reference to oral contraceptive practice.
  393. The Narangwal population study: integrated health and family planning services.
  394. The National Family Planning Program in Korea.
  395. A national family planning program: the United States experience from 1968 to 1974.
  396. National family planning programme of Bangladesh-past, present and future.
  397. National family planning programs of five selected IGCC countries: Indonesia, Malaysia, Philippines, Singapore, Thailand: status report, 1974.
  398. National health services and family planning: Thailand, a case study.
  399. Natural approach to family planning.
  400. Natural family planning.
  401. Natural family planning.
  402. Natural family planning.
  403. Natural family planning. Rev. ed.
  404. Natural family planning: selected bibliography.
  405. Natural law and planned parenthood.
  406. The need for an action programme in population and family planning for the organised sector.
  407. Need-based family planning programmes: content and treatment guidelines for T.V. producers.
  408. The Nepal FP-MCH project delivery of family planning service: a description.
  409. Neuroendocrine dysfunction in galactorrhea-amenorrhea after oral contraceptive use.
  410. New aspect of local chemical contraception. Clinical study of a quaternary ammonium salt carried out by ten gynecologists and general practitioners. [Nouvel aspect de la contraception chimique locale. Etude clinique d'un sel d'ammonium quaternaire realisee par dix medecins gynecologues et generalistes.]
  411. New aspects of the thrombogenic effect of oral contraceptives.
  412. New aspects on thrombosis and oral contraceptives. [Nya aspekter pa trombos och peroral antikonception.]
  413. A new audiovisual educational tool for family planning.
  414. New patterns in China's family planning.
  415. New possibilities of contraception with IUDs and computer analysis of actual results. [Ujabb lehetosegek az intrauterin fogamzasgatlasban es a gyakorlati eredmenyek szamitogepes elemzese.]
  416. New results in the field of hormonal contraceptives. [Neue ErGebnisse auf dem gebiet der hormonalen Kontrazeptiva.]
  417. A new type of contraceptive.

     

  418. NHS family planning services.
  419. Nigeria. (Family planning programs)
  420. Nodular transformation (NT) of the liver and intrahepatic hemorrhage in women on oral contraceptives. (Abstract only)
  421. Nonphysician distribution of contraception in Latin America and the Caribbean.
  422. Nonpuerperal breast secretion: its relation to the use of oral contraceptives.
  423. Norway to assist India's family planning programme.
  424. A note on data requirements on fertility and family planning in India.
  425. Nurses attitudes to contraception and sterilisation.
  426. Nurses in family planning: a manual for counseling, patient advocacy, and clinical care.
  427. Nutrition and family planning.
  428. Nutrition and family planning.
  429. Nutrition and family planning. [Nutrition et planification familiale.]
  430. Nutritional care for family planning patients (nutrition and family planning)
  431. The objective and subjective effects of modern methods of contraception. [Les incidents objectifs et subjectifs des moyens modernes de contraception.]
  432. Objectives of seminar/workshop. (Family planning services)
  433. Obstacles to family planning practice in urban Morocco.
  434. Ocular complications of oral contraception. [Les complications oculaires de la contraception.]
  435. Ocular effects of oral contraceptives: 1. studies in the dog.
  436. Oestrogenic potency and oral contraceptives.
  437. Offering family planning at the work site.
  438. On family planning associations and development of population policy and programs.
  439. On Optimum strategy for setting targets in family planning.
  440. On Problems of Family Planning in Israel.
  441. On the action of a two phase oral contraceptive. (Abstract only)
  442. On the application of systems analysis in family planning in India.
  443. On the family planning programme in Gandhigram.
  444. On the Indian experiment in family planning: a review and suggestions for the future.
  445. On the psychology of adolescents' use of contraceptives.
  446. Open session: Depo-Provera, injectable, as a contraceptive: report to the committee.
  447. Oral contraception and lactation. [Contraception orale et allaitement.]
  448. Oral contraception and rifampicin. [Contraception orale et rifampicine.]
  449. Oral contraception and uterine size - ultrasonic study.
  450. Oral contraception for men. [La contraception orale chez l'homme.]
  451. Oral contraception in Melbourne, 1961-1971.
  452. Oral contraception.
  453. Oral contraception.
  454. Oral contraceptive agents.
  455. Oral contraceptive continuation rates in the Singapore national program, 1966-1972.
  456. Oral contraceptive hormones, folate metabolism, and the cervical epithelium.
  457. Oral contraceptive labeling.
  458. Oral contraceptive pill hypertension.
  459. Oral contraceptive program in a rural area.
  460. Oral contraceptives and ascorbic acid.
  461. Oral contraceptives and birth defects. (Abstract only)
  462. Oral contraceptives and breast cancer. [Anticinceptivos orais e cancer de mama.]
  463. Oral contraceptives and breast cancer: progress report of an epidemiological study.
  464. Oral contraceptives and congenital limb-reduction defects.
  465. Oral contraceptives and congenital limb-reduction defects: reply. (Letter to the editor)
  466. Oral contraceptives and death from myocardial infarction.
  467. Oral contraceptives and fibrocystic breast disease.
  468. Oral contraceptives and genital cancers. [Contraceptifs oraux et cancers genitaux.]
  469. Oral contraceptives and gingival reactions. [Contraceptifs oraux et reactions gingivales.]
  470. Oral contraceptives and human cervical mucus lipids.
  471. Oral contraceptives and hypertension.
  472. Oral contraceptives and hypertension. [Orale kontraceptiva og hypertension.]
  473. Oral contraceptives and liver tumours. (Letter to the editor)
  474. Oral contraceptives and myocardial infarction in young women: a further report.
  475. Oral contraceptives and myocardial infarction.
  476. Oral contraceptives and myocardial infarction. (Letter to the editor)
  477. Oral contraceptives and myocardial infarction. (Letter to the editor)
  478. Oral contraceptives and myocardial infarction. (Letter to the editor)
  479. Oral contraceptives and nutrition.
  480. Oral contraceptives and premenstrual tension. (Letter to the editor)
  481. Oral contraceptives and premenstrual tension. (Letter to the editor)
  482. Oral contraceptives and stroke in young women: associated risk factors.
  483. Oral contraceptives and the liver.
  484. Oral contraceptives and the liver. [Orale Kontrazeptiva und Leber.]
  485. Oral contraceptives and thromboembolism: a reassessment.
  486. Oral contraceptives and thrombosis. [Contraceptifs oraux et thromboses.]
  487. Oral contraceptives and venous thrombosis.
  488. Oral contraceptives and vitamin requirements. (Letter to the editor)
  489. Oral contraceptives and vitamins: a review.
  490. Oral contraceptives as related to cancer and benign lesions of the breast.
  491. Oral contraceptives during pregnancy and fetal chromosome findings. [Orale Kontrazeptiva wahrend der Schwangerschaft und fetaler Chromosomenb efund.]
  492. Oral contraceptives in women over 34.
  493. Oral contraceptives in women over 34. (Letter to the editor)
  494. Oral contraceptives with cerebro-vascular complications. (Abstract only)
  495. Oral contraceptives, ABO blood groups, and in vitro fibrin formation.
  496. Oral contraceptives, immunoreactions and rheumatic symptoms. (Abstract only)
  497. Oral contraceptives, norethindrone and mestranol: effect on zinc and copper metabolism. (Abstract only)
  498. Oral contraceptives, serum folate, and hematologic status.
  499. Oral contraceptives, serum folate, and hematologic status. (Letter to the editor)
  500. Oral contraceptives, some pregnancy tests may increase risk of a rare birth defect.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.